Keloid Treatment Study
Part of Skin clinical trials.
This trial tests a new way to treat keloids by injecting medicine directly into the scar. It may help people with thick, raised scars that don't go away on their own.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have a keloid (a raised, thick scar that grows beyond the original wound).
- You cannot be pregnant or breastfeeding.
- You cannot have a skin disease that might affect the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests injections of polidocanol (a medication that shrinks blood vessels) combined with a steroid to treat keloids and hypertrophic scars—raised, thickened scars that form after injury. The goal is to flatten and improve the appearance of these scars.
This study looks at how keloid scars form by studying the skin cells. You may be able to join if you are at least 18 years old, have a keloid, and are already planning to have surgery to remove it.
This trial tests whether an injection of triamcinolone or verapamil works better to shrink keloids and improve their appearance. It is for people who have had a keloid for less than five years and have a moderate to severe scar score.
This study tests an experimental injection (9MW3811) to help improve the appearance and feel of thick, raised scars that haven't improved on their own in at least 6 months. The treatment may reduce redness, firmness, and other signs of abnormal scarring.
This study tests whether adding a cold therapy treatment (cryotherapy) to standard steroid injections can improve keloids and hypertrophic scars. If you are already getting steroid shots for your scar, you may be able to join and get both treatments on different parts of one scar.
This study compares two medicines (bleomycin and a mix of 5-FU plus triamcinolone) injected directly into keloids to see which works better. It may help reduce scarring.
Hear when a new Scar, Hypertrophic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.